Delivery Order SPE2DB22D1202-SPE2DB25FVCP6
Award Date 6/18/25
Potential Completion Date 6/20/25
Potential Value $4.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $7,826.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive procurement of specialized diabetic medical devices. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the delivery order through its corporate office division....
- The Defense Logistics Agency awarded a delivery order valued at $1,896.50 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 pods (Generation 5) with a 5-unit configuration. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by December 3, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,603.61 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 continuous glucose monitoring system pods (Generation 5), with performance in Conshohocken, Pennsylvania. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as the prime contractor under this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a competitively awarded delivery order valued at $1,566.49 for OmniPod 5 Dexcom G7 pods (Generation 5) with a 5-second delivery interval. The order, issued on September 2, 2025, with completion targeted for September 3, 2025, represents a firm fixed-price transaction with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a Delivery Order valued at $3,775.06 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 pods (Generation 5), 5-pack units. The order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work from its corporate office location. This delivery order represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $5,179.06 for OmniPod 5 Dexcom G7 generation 5 insulin delivery pods. This is a firm fixed price, non-set-aside contract with a completion date of September 25, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $2,467.30 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods, with performance in Conshohocken, Pennsylvania and completion by December 26, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The delivery...
- The Defense Logistics Agency awarded a $3,951.77 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 pods (Generation 5), with a completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child order under AmerisourceBergen's larger contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods valued at $4,737.07. The non-competitive delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a small-value transaction for specialized diabetes management medical devices. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $8,040.58 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, which was competitively awarded without set-aside provisions, has a performance completion date of December 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite...